The U.S. Food and Drug Administration (FDA) has approved bemotrizinol, a sunscreen ingredient previously available in Europe and parts of Asia, for use in over-the-counter (OTC) products in the United States. This marks the first addition to the FDA’s list of permitted sunscreen active ingredients since the late 1990s. (fda.gov)
Bemotrizinol is a broad-spectrum ultraviolet (UV) filter that provides protection against both UVA and UVB rays. Dermatologists highlight its photostability, meaning it does not degrade with sun exposure, making it suitable for individuals who spend significant time outdoors. (fda.gov)
For outdoor athletes, bemotrizinol offers several advantages:
-
Enhanced Protection: It effectively shields against UVA and UVB rays, reducing the risk of skin damage and premature aging.
-
Durability: Its photostable nature ensures consistent protection during extended outdoor activities.
-
Comfort: Formulations containing bemotrizinol are less greasy and do not leave a white residue, improving user experience.
However, it’s important to note that while bemotrizinol enhances sunscreen efficacy, it should be part of a comprehensive sun protection strategy. Athletes should continue to reapply sunscreen regularly, choose water-resistant formulas, seek shade when possible, and wear sun-protective clothing. (fda.gov)
The approval of bemotrizinol represents a significant advancement in sunscreen technology, offering improved protection for outdoor enthusiasts.